skip to Main Content
  • Call Now: 1 (888) 400-3201
  • Login
  • Support
  • SALES
AZZLY
  • Who We Serve
    • Behavioral Healthcare/Mental Healthcare Providers
      • Community-Based Outpatient
      • Inpatient Psychiatric Rehabilitation
      • Medication Withdrawal Management
      • Residential Treatment
      • Eating Disorders-Outpatient-Residential
    • Addiction Treatment Providers
      • Medication Assisted Treatment
      • Abstinence-Based Treatment
      • Detox Inpatient/Residential/Outpatient
      • Office-Based Opioid Treatment (OBOT) Programs
      • Opioid Treatment Programs (OTP)
  • Software Features
    • Electronic Health Record
    • EChart - Integrated Care Pathways™
    • Outcome Measurement Tools
    • Integrated Billing/Claims/Clearinghouse
    • Reports/Analytics Engine
    • Capitation
    • Telehealth 💻
    • Mobility
    • Patient Engagement
  • Packages
    • Enterprise Solution
    • Pro Solution
    • Basic Solution
  • Implementation Services
    • Guided Training
    • Self-Paced e-Learning
    • Consulting
  • About AZZLY
    • Blog
    • Leadership Team
    • Preferred Partners
    • Contact
    • Talking Treatment™ Podcast Series 🎧
    • Resources
    • FAQ
    • Careers
Dealing With Stress And Addition

Easier to Prescribe Opioids Than Buprenorphine – Experts Lament Patient Barriers to Medication-Assisted Treatment

  • April 9, 2019
  • Uncategorized

A panel of experts recently appeared before a Medicaid and CHIP Payment and Access Commission (MACPAC) in early 2019 to discuss barriers to medication-assisted treatment (MAT). Despite some headway, patients on Medicaid continue to face a number of barriers to…

Continue Reading→
Questions To Ask Before Purchasing An EMR Or EHR

FDA Approves Postpartum Depression Drug Zulresso, But Concerns Arise Over Cost

  • April 2, 2019
  • Industry News, Legislation

In mid-March, the FDA approved the postpartum depression drug brexanolone, providing an option to millions of women who suffer from postpartum depression. Brexanolone is the first federally-approved drug of its kind to be designed specifically to treat postpartum depression. The…

Continue Reading→
AZZLY Rize - Introducing New Technologies In Your Workplace

WE NEED YOUR SIGNATURE – Make Counseling and Therapeutic Intervention Mandatory for Medication-Assisted Treatment (MAT) Funding

  • February 7, 2019
  • Industry News, Legislation, Medication-Assisted Treatment

AZZLY joins the Behavioral Health Association of Providers (BHAP) in asking you to support the behavioral health industry by signing this petition. This petition will be delivered to President Trump, the Senate, and the House of Representatives and would urge…

Continue Reading→
Signs You Need A New EHR

“Worst Public Health Crisis Since AIDS”: Barriers for Opioid Use Disorder Patients Seeking Treatment

  • January 25, 2019
  • Industry News, Legislation

If you’re reading this post, you likely already know the seriousness of the opioid epidemic currently in the United States. The opioid epidemic is the largest the U.S. has faced in decades, arguably since the emergence of AIDS. Opioid use…

Continue Reading→
It Was The Best Of Times, It Was The Worst Of Times

Drug Distributor McKesson Shipped Five Million Opioid Pills to West Virginia Town of 400 in Two Years

  • January 21, 2019
  • Industry News, Legislation

In 2018, five drug distribution executives were summoned to testify before the House Energy and Commerce Committee oversight panel. The panel covered more than a dozen case studies, but one of the most striking was the case of Kermit, West…

Continue Reading→

Lawyer Behind Multibillion-Dollar Big Tobacco Lawsuit is Now Suing Big Opioid

  • December 20, 2018
  • Industry News, Legislation

Former Mississippi attorney general Mike Moore famously orchestrated a $250 billion settlement from major tobacco companies in the 1990s. Now he's back to take on the opioid industry. CBS covered Moore and his efforts in a Sunday, December 16, episode…

Continue Reading→
United States Capitol Building In Washington DC USA

Health and Human Services Will Allow More Waivers to IMD Exclusion From Medicaid

  • December 3, 2018
  • Industry News, Legislation

Health and Human Services Secretary Alex Azar announced this November in a speech to the National Association of Medicaid Directors that the Centers for Medicare & Medicaid Services would allow states to waive the IMD exclusion, "giving states more flexibility…

Continue Reading→

Finding the Right Weapons to Treat Substance Use Disorders in Veterans

  • November 12, 2018
  • Educational, Industry News, Medication Management and PDMPs

Related: Resources for Veterans and Service Members (February 2021) This article cites several studies reported in Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Read AZZLY's write-up of the Surgeon General's report from September 2018 or…

Continue Reading→
Know About Premium Training Package

Surgeon General Releases “Spotlight on Opioids” Document

  • September 25, 2018
  • Educational, Industry News, Medication-Assisted Treatment

Last Thursday, Vice Admiral Jerome Adams, the U.S. Surgeon General, released Facing Addiction in America: The Surgeon General's Spotlight on Opioids as part of his ongoing effort in educating the public about substance use disorders. The document, 40 pages long…

Continue Reading→

Senate Passes Opioid Crisis Response Act – Here’s What’s in It

  • September 17, 2018
  • Industry News, Legislation, Medication-Assisted Treatment

Update: On Wednesday, October 24, 2018, President Trump officially signed the Opioid Crisis Response Act into law. Monday evening, September 17, the United States Senate passed the Opioid Crisis Response Act of 2018, a legislative package of more than 70 bills…

Continue Reading→
  • Page 1
  • Page 2
  • Next
Software-Advisor-Icon-White
National Association of Addiction Treatment Providers White Logo
Capterra White Logo with Four and a Half Stars
Microsoft Azure Logo - Secured Hosted
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Spotify
Independent Coalition of Ethical Treatment Providers
American Owned & Operated. © Copyright 2023 AZZLY. All rights reserved | Home | Sitemap | Privacy Policy | Services Agreement | 1 (888) 400-3201 | Orlando, FL/Vero Beach, FL
I'm a consultant interested in contacting AZZLY.

Consultant

  • This field is for validation purposes and should be left unchanged.

  • Who We Serve
    • Behavioral Healthcare/Mental Healthcare Providers
      • Community-Based Outpatient
      • Inpatient Psychiatric Rehabilitation
      • Medication Withdrawal Management
      • Residential Treatment
      • Eating Disorders-Outpatient-Residential
    • Addiction Treatment Providers
      • Medication Assisted Treatment
      • Abstinence-Based Treatment
      • Detox Inpatient/Residential/Outpatient
      • Office-Based Opioid Treatment (OBOT) Programs
      • Opioid Treatment Programs (OTP)
  • Software Features
    • Electronic Health Record
    • EChart - Integrated Care Pathways™
    • Outcome Measurement Tools
    • Integrated Billing/Claims/Clearinghouse
    • Reports/Analytics Engine
    • Capitation
    • Telehealth 💻
    • Mobility
    • Patient Engagement
  • Packages
    • Enterprise Solution
    • Pro Solution
    • Basic Solution
  • Implementation Services
    • Guided Training
    • Self-Paced e-Learning
    • Consulting
  • About AZZLY
    • Blog
    • Leadership Team
    • Preferred Partners
    • Contact
    • Talking Treatment™ Podcast Series 🎧
    • Resources
    • FAQ
    • Careers